(19)
(11) EP 4 568 660 A1

(12)

(43) Date of publication:
18.06.2025 Bulletin 2025/25

(21) Application number: 23851115.8

(22) Date of filing: 11.08.2023
(51) International Patent Classification (IPC): 
A61K 31/137(2006.01)
A61K 9/14(2006.01)
A61P 37/08(2006.01)
A61K 9/00(2006.01)
A61K 47/26(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/137; A61P 37/08; A61K 9/0075
(86) International application number:
PCT/AU2023/050756
(87) International publication number:
WO 2024/031148 (15.02.2024 Gazette 2024/07)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 11.08.2022 AU 2022902269
11.08.2022 US 202217886124

(71) Applicant: De Motu Cordis Pty Ltd
Windsor, QLD 4030 (AU)

(72) Inventors:
  • FRASER, John
    Windsor, Queensland 4030 (AU)
  • DALZIEL, Sean Mark
    Red Hill, Queensland 4059 (AU)
  • ILEY, Teresa
    Melbourn Hertfordshire SG8 6DN (GB)
  • BRAZIER, Jonathan
    Melbourn Hertfordshire SG8 6DN (GB)
  • LYNCH, Patrick Joseph
    Windsor, Queensland 4030 (AU)
  • FREDATOVICH, John
    Windsor, Queensland 4030 (AU)
  • TROUT, Benjamin Barnaby
    Windsor, Queensland 4030 (AU)

(74) Representative: HGF 
HGF Limited 1 City Walk
Leeds LS11 9DX
Leeds LS11 9DX (GB)

   


(54) INHALABLE EPINEPHRINE FORMULATION